Table 2 Overall and disease-free survival based on the NMU expression of peri- and intra-tumor tissue
From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
| Group | case | Overall survival | Disease-free survival | ||||
|---|---|---|---|---|---|---|---|
| 1 year (%) | 3 years (%) | 5 years (%) | 1 year (%) | 3 years (%) | 5 years (%) | ||
| All | 228 | 69.7 | 46.1 | 38.9 | 43.4 | 30.3 | 26.2 |
| Peri-tumor | |||||||
| Low | 133 | 72.2 | 54.9 | 46.6 | 46.6 | 36.1 | 32.2 |
| High | 95 | 66.3 | 33.7 | 28.4 | 38.9 | 22.1 | 17.4 |
| Intra-tumor | |||||||
| Low | 137 | 69.3 | 48.9 | 41.6 | 48.2 | 31.4 | 29.3 |
| High | 91 | 70.3 | 41.8 | 34.8 | 42.2 | 28.9 | 22.0 |